DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Respiratory Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Respiratory Failure (96)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include respiratory failure. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 96   Next >>

Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 108.0 kg (237.6 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from Netherlands on 2012-08-20

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Pericarditis, Cerebral Artery Embolism, Respiratory Failure, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-17

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Dyspnoea, Vomiting, Nausea, Hyperreflexia, Encephalopathy, Extensor Plantar Response, Endophthalmitis, Lung Consolidation, Respiratory Failure, Emotional Disorder, CSF Pressure Increased, Reflexes Abnormal, Lethargy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Amsacrine
    Dosage: 220 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-28

Clofarabine
    Dosage: 18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25

Cytarabine
    Dosage: 3600 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25

Other drugs received by patient: Valaciclovir



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-08-16

Patient: female, weighing 7.4 kg (16.3 pounds)

Reactions: Capillary Leak Syndrome, Hepatic Function Abnormal, Respiratory Failure, Disease Progression, Ascites

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 11 mg (40 mg/m2), qdx5
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Cyclophosphamide
    Dosage: 80 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Cytarabine
    Dosage: 15 mg, od
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-28
    End date: 2010-07-28

Cytarabine
    Indication: Chemotherapy

Etoposide
    Dosage: 28 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 6 mgr, od
    Indication: Chemotherapy
    Start date: 2010-07-28
    End date: 2010-07-28

Prednisolone
    Indication: Chemotherapy

Prednisolone
    Dosage: 6 mgr, od
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-28
    End date: 2010-07-28

Other drugs received by patient: Itraconazole; Vancomycin; Dexamethasone; Filgrastim; Teicoplanin; Ciprofloxacin HCL; Ciprofloxacin HCL; Tramadol HCL; Vancomycin; Ceftazidime; Zofran; Vancomycin; Furosemide; Cotrim; Vancomycin; Vitamin K TAB; Cotrim; Itraconazole; Vancomycin; Vancomycin; Omeprazole; Acetaminophen; Ciprofloxacin; Furosemide; Ceftazidime; Furosemide; Omeprazole



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female

Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 52 mg/m2, dose level 3
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-13
    End date: 2012-07-17

Cytarabine
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-12



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-08-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Bronchopulmonary Aspergillosis, Dyspnoea, Respiratory Failure, Sepsis, Hepatic Lesion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 18.48 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Cytarabine
    Dosage: 369.66 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Idarubicin HCL
    Dosage: 22.18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Other drugs received by patient: Piperacillin W



Possible Cytarabine side effects in 70 year old male

Reported by a physician from Austria on 2012-08-14

Patient: 70 year old male, weighing 94.0 kg (206.8 pounds)

Reactions: Respiratory Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Atracurium Besylate
    Dosage: 120 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-18

Cytarabine
    Dosage: 205 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-13

Etoposide
    Dosage: 205 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-13

Idarubicin HCL
    Dosage: 24 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-13

Other drugs received by patient: Colidimin; Tazonam; Vfend



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Disseminated Intravascular Coagulation, Hypotension, Continuous Haemodiafiltration, Pyrexia, Tumour Lysis Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 157 mg

Daunorubicin HCL
    Dosage: 80 mg

Etoposide
    Dosage: 15.7 mg



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from Belgium on 2012-08-10

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Pericarditis, Cerebral Artery Embolism, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Floxacillin Sodium

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-08-09

Patient: male, weighing 75.0 kg (165.0 pounds)

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Start date: 2012-06-15

Daunorubicin HCL
    Start date: 2012-06-15

Revlimid
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-29

Other drugs received by patient: Ciprofloxacin HCL; Temazepam; Lisinopril; Fluconazole; Colistin



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-08-09

Patient: male

Reactions: Respiratory Failure, Chills, Pancytopenia, Condition Aggravated, Pyrexia, Lung Infection Pseudomonal, Septic Shock, Oxygen Saturation Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Alkeran
    Dosage: 234mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-15
    End date: 2012-02-15

Carmustine
    Dosage: 500mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-10
    End date: 2012-02-10

Cytarabine
    Dosage: 668mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-11
    End date: 2012-02-14

Etoposide
    Dosage: 167mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-11
    End date: 2012-02-14



Possible Cytarabine side effects in male

Reported by a physician from Belgium on 2012-08-06

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Cerebral Artery Embolism, Pericarditis, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Floxacillin Sodium

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female, weighing 11.1 kg (24.4 pounds)

Reactions: Hypotension, Neoplasm Progression, Tumour Compression, Hepatitis, Chloroma, Pseudomonas Test Positive, Respiratory Failure, Cholangitis, Intracranial Pressure Increased, Hydrocephalus, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 2948 mg
    End date: 2011-11-01

Mitoxantrone Hydrochloride
    Dosage: 4 mg
    End date: 2011-11-08



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-02

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Dyspnoea, Vomiting, Nausea, Encephalopathy, Hyperreflexia, Extensor Plantar Response, Lung Consolidation, Respiratory Failure, CSF Pressure Increased, Emotional Disorder, Reflexes Abnormal, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 220 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-28

Clofarabine
    Dosage: 18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25

Cytarabine
    Dosage: 3600 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25

Other drugs received by patient: Valaciclovir



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-08-02

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10

Clofarabine
    Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-07-30

Patient: male, weighing 75.0 kg (165.0 pounds)

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Start date: 2012-06-15

Daunorubicin HCL
    Start date: 2012-06-15

Revlimid
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-29

Other drugs received by patient: Fluconazole; Ciprofloxacin HCL; Temazepam; Lisinopril; Colistin



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-07-27

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10

Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-07-26

Patient: female, weighing 11.1 kg (24.4 pounds)

Reactions: Hyperbilirubinaemia, Respiratory Failure, Cholangitis, Blood Culture Positive, Hypotension, Pseudomonas Infection, Hydrocephalus, Hepatitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 2948 mg
    End date: 2011-11-01

Mitoxantrone Hydrochloride
    Dosage: 4 mg
    End date: 2011-11-08



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-24

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Lung Consolidation, Dyspnoea, Respiratory Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 220 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-28

Clofarabine
    Dosage: 18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25

Cytarabine
    Dosage: 3600 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-07-24

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-07-23

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10

Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B



Possible Cytarabine side effects in 68 year old male

Reported by a physician from Italy on 2012-07-18

Patient: 68 year old male

Reactions: Tumour Lysis Syndrome, Renal Failure, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Levofloxacin; Allopurinol; Allopurinol; Normase; Mycostatin; Allopurinol; Zofran; Lasix



Possible Cytarabine side effects in 59 year old female

Reported by a physician from United States on 2012-07-18

Patient: 59 year old female

Reactions: Respiratory Failure, Platelet Count Decreased, Febrile Neutropenia, Upper Gastrointestinal Haemorrhage, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-11

Cytarabine
    Dosage: 1920 mg, cyclic
    Start date: 2012-05-16
    End date: 2012-05-16

Sprycel
    Dosage: 600 mg, cyclic
    Administration route: Oral
    Start date: 2012-05-16
    End date: 2012-05-26

Sprycel
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-11



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-07-17

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-12

Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-11

Cytarabine
    Dosage: 3800 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-12

Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-07-16

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin



Possible Cytarabine side effects in 24 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-11

Patient: 24 year old female

Reactions: Pulmonary Alveolar Haemorrhage, Neutropenic Sepsis, Escherichia Bacteraemia, Aplasia, Stem Cell Transplant, Zygomycosis, Respiratory Failure, Bone Marrow Failure, Staphylococcal Bacteraemia, Pathogen Resistance, Aspergillus Test Positive

Drug(s) suspected as cause:
Cytarabine
    Indication: Acute Myeloid Leukaemia

Etoposide
    Indication: Acute Myeloid Leukaemia

Idarubicin Hydrochloride
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Pegfilgrastim (Pegfilgrastim)



Possible Cytarabine side effects in

Reported by a physician from United States on 2012-07-05

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Dyspnoea, Stomatitis, Vomiting, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Prednisone
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Prednisone
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Other drugs received by patient: Filgrastim; Unknown Medication; Leucovorin Calcium



Possible Cytarabine side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-04

Patient: 59 year old male

Reactions: Viral Infection, Pneumonia, Respiratory Failure, Acute Myeloid Leukaemia, Neutropenic Sepsis, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: continuous iv infusion for 7 days

Idarubicin HCL
    Dosage: 12 mg/m2/day for three days

Methylprednisolone
    Indication: Immunosuppression

Mycophenolate Mofetil
    Indication: Immunosuppression

Sirolimus

Tacrolimus
    Indication: Immunosuppression



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017